作为阿尔法病毒病毒复制抑制剂的4 - 替代的2 - 二胺
Atefeh Garzan1, S Kaleem Ahmed1, Nicole N Haese2
1Scientific Platforms Division, Southern Research, 2000 ninth Avenue South, Birmingham, Alabama 35205, United States.
Journal of medicinal chemistry
|December 2, 2024
概括
研究人员开发了一种新化合物,N-(4-(3-((4-cyanophenyl) amino) phenyl)thiazol-2-yl)-2-(methylthio) nicotinamide (26),用于对抗奇孔尼亚病毒 (CHIKV). 这种强大的抑制剂显示出显著的抗病毒活性和改善的稳定性.
科学领域:
- 病毒学 病毒学
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
背景情况:
- 奇孔古尼亚病毒 (CHIKV) 构成了严重的全球健康威胁.
- 目前对CHIKV的治疗方法有限,需要开发新型抗病毒药物.
- 化合物1作为CHIKV抑制剂最初显示出有前途.
研究的目的:
- 为了优化CHIKV抑制剂的抗病毒功效和类似药物的特性.
- 发现和描述具有针对CHIKV增强疗效的新型化合物.
- 为了阐明作用机制,并评估化合物的体内疗效.
主要方法:
- 进行了结构-活性关系 (SAR) 研究,以指导化合物优化.
- 通过测量EC50,EC90和病毒标位降低 (VTR) 来评估抗病毒活性.
- 在正常的人体皮肤纤维细胞 (NHDF) 细胞中评估了细胞毒性.
- 使用微小脂质代谢 (MLM) 试验确定了代谢稳定性.
- 作用机制研究涉及分析病毒RNA翻译和蛋白质合成.
- 在体内疗效在CHIKV感染的小鼠模型中进行了测试.
主要成果:
- 化合物1对CHIKV表现出适度的抗病毒活性 (EC50 = 0.6μM),细胞毒性低 (CC50 = 132μM).
- 由SAR研究得出的化合物26显著改善了功效 (EC90 = 0.45μM) 和疗效 (VTR = 8.7日志).
- 与化合物1相比,化合物26显示出增强的代谢稳定性 (t1/2 = 74分钟).
- 机制研究表明,化合物26通过阻断病毒RNA转化和蛋白质合成来抑制CHIKV复制.
- 化合物26已在小鼠体内证明对CHIKV感染的有效性.
结论:
- 化合物26代表了一种强大而有前途的治疗候选人,用于治疗 Chikungunya 病毒感染.
- 化合物26的优化结构提供了改善的抗病毒活性,代谢稳定性和疗效.
- 对化合物26的进一步调查证明其作为一种潜在的抗CHIKV药物的开发是有必要的.
更多相关视频
相关概念视频
siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Preparation of 1° Amines: Azide Synthesis
Direct alkylation of ammonia produces polyalkylated amines, along with a quaternary ammonium salt. To exclusively prepare primary amines, the azide synthesis method can be used.
Azide ions act as good nucleophiles and react with unhindered alkyl halides to form alkyl azides. Alkyl azides do not participate in further nucleophilic substitution reactions, thereby eliminating the chances of polyalkylated products. Alkyl azides are reduced by hydride-based reducing agents, like lithium aluminum...
Azide ions act as good nucleophiles and react with unhindered alkyl halides to form alkyl azides. Alkyl azides do not participate in further nucleophilic substitution reactions, thereby eliminating the chances of polyalkylated products. Alkyl azides are reduced by hydride-based reducing agents, like lithium aluminum...
Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...


